Differential gene expression in lesional skin may signify immune-mediated lung parenchymal damage in patients with dermatomyositis

J Am Acad Dermatol. 2023 May;88(5):1201-1204. doi: 10.1016/j.jaad.2022.12.040. Epub 2023 Jan 12.

Authors

Katharina Shaw¹, Nicole Doudican², Arnav Mishra², Nicholas Frazzette², Avrom S Caplan², Alisa Femia², John Carucci²

Affiliations

¹ Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: kshaw17@bwh.harvard.edu.
² The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.

PMID: 36641011
DOI: 10.1016/j.jaad.2022.12.040

No abstract available

Keywords: NanoString; biomarkers; dermatomyositis; interstitial lung disease; translational research.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Dermatomyositis* / genetics
Gene Expression
Humans
Lung
Lung Diseases, Interstitial*
Skin Diseases*